Nathan Hubbard

Experience

• 

  PKF (UK) LLP

  Sept 2002 - Aug 2005

  Associate

  Audit work on small owner managed businesses.Personal and corporation tax computations and planning.Performing finance function for smaller clients including preparation of draft statutory accounts. Exposure to a variety of financial software packages such as Sage, SAP and Exchequer.Preparation and submission of VAT and PAYE returns.Due diligence work and preparation of financial models.

• 

  PwC

  Sept 2005 - Jan 2008

  Executive

  Assistant manager role on engagements for non-listed and listed companies with a turnover of up to £100m.Executive role as part of a much larger team on engagements for non-listed and listed companies with a turnover of over £1,500m.Working within audit teams of between 1 and 16 members.Understanding and documenting IT system controls.Preparation of cash flows and financial statements.Controls assessment and testing.Audit work under UK GAAP, US GAAS and IFRS as well as Sarbanes-Oxley work.Varied client base, including; manufacturing, bio-tech, property development, high technology and computing. Show less

• 

  Grant Thornton UK LLP

  Feb 2008 - Sept 2016

  Associate Director - Corporate Finance

  - Provision of financial due diligence for corporates, banks & private equity houses. Working on both listed, multi-national & owner-managed businesses on a variety of transactions both in the UK & abroad. - Led a growing Cambridge team while project managing multiple transactions. Provided opinions & advice up to Board level.

• 

  AstraZeneca

  Sept 2016 - now

  Responsibilities- Led the team in preparing Budgets & 10-year plans presenting to CEO/CFO ahead of Board approvals.- Led the Group relationship with the Japan business, bringing insight & understanding to CFO & CEO.Achievements- Stablise team following the departure of 2 team members while maintaining high-quality delivery of forecasts.- Improve outputs & insight to C-Suite during the challenging COVID business environment & home-working.- Closely invovled in the design & implementation of the new 10-year planning process.- Helped plan & drive the post-acquisition Alexion ($39bn acquisition in 2021) financial integration workstreams. Show less Responsibilities- Key Group deliverables: monthly performance reporting, quarterly rolling forecast updates, preparation of Remuneration Committee/Board papers & briefing of CFO & VP Financial Controller. Co-ordination of c.12 regional Finance Heads & other ad-hoc queries/deliverables to CEO/CFO/Board/etc as required.-Led team of 3 direct reports while coordinating deliverables from a wider team of c.20.-Preparation of robust & insightful briefing material. Influencing senior management thinking & decision making.Achievements:-Significant step-up to take-on a very visible role. Presented to monthly meetings of Group Financial Heads & led discussions on key decisions, allocation/negotiation of year-end targets.-Designed & coordinated briefing materials & then presented to CEO & CFO on key strategic decisions. Show less Responsibilities- Established the cash flow forecasting capabilities from a low base. Designed & implemented both a rolling 24 month forecast & a 10-year strategic cash flow forecast. Presented & influenced decisions by CFO & CEO.Achievements- Promoted to Director in recognition of the successes delivered by the team & I.- Established system & processes with significant improvement in accuracy & creditability of forecasts.- Worked closely with Treasury in respect of debt refinancing & meeting with key Credit Rating Agencies (Moody’s, S&P, etc). Show less Responsibilities- Established the cash flow forecasting capabilities from a low base. Designed & implemented both a rolling 24 month forecast & a 10-year strategic cash flow forecast. Presented & influenced decisions by CFO & CEO.Achievements- Promoted to Director in recognition of the successes delivered by the team & I.- Established system & processes with significant improvement in accuracy & creditability of forecasts.- Worked closely with Treasury in respect of debt refinancing & meeting with key Credit Rating Agencies (Moody’s, S&P, etc). Show less

  • Finance Director – BioPharma R&D FP&A

    Apr 2023 - now

  • Director – Group Planning, Group FP&A

    Jul 2020 - Apr 2023

  • Director – Business Performance, Group FP&A

    Oct 2018 - Jul 2020

  • Interim Head of Business Performance, Group FP&A

    Jun 2018 - Oct 2018

  • Director – Group Cash Flow Planning & Reporting

    Apr 2018 - Jun 2018

  • Manager – Group Cash Flow Planning & Reporting, Group FP&A

    Sept 2016 - Apr 2018